Technology

  Market Overview The global Deepfake Detection Market was valued at USD 0.6 billion in 2025 and is projected to reach USD 15.1 billion by 2036 , growing from an estimated USD 0.99 billion in 2026 at a CAGR of 37.2 % during the forecast period of 2026–2036 . The market is gaining significant momentum as organizations increasingly adopt advanced technologies to identify AI-generated and manipulated images, videos, audio recordings, and digital content. Deepfake detection solutions use artificial intelligence, machine learning, deep learning, facial recognition, voice analysis, and digital forensics to identify synthetic media and verify content authenticity. These technologies are becoming increasingly important across banking, financial services, government, defense, healthcare, media, entertainment, and telecommunications. The growing availability of generative AI tools and sophisticated synthetic media techniques is increasing the demand for reliable detection platforms that...

  Market Overview The global Digital Product Passport (DPP) Market was valued at approximately USD 0.2 billion in 2025 and is projected to reach USD 5.1 billion by 2035, registering a CAGR of 41.2% during the forecast period of 2025–2035. Digital Product Passport solutions provide a digital record of a product's identity, materials, manufacturing processes, origin, environmental impact, repairability, and end-of-life information throughout its lifecycle. These solutions are gaining importance as manufacturers, retailers, and supply chain stakeholders focus on improving product transparency, traceability, sustainability, and regulatory compliance. Technologies such as cloud computing, blockchain, QR codes, RFID, and Internet of Things (IoT) are being integrated into DPP platforms to enable secure information sharing and product-level tracking. Increasing adoption across automotive, batteries, consumer electronics, textiles, apparel, and industrial manufacturing is further support...

  Market Overview The global Edge Computing Market was valued at USD 141.1 billion in 2025 and is projected to reach USD 286.6 billion by 2035 , registering a CAGR of 7.3% during the forecast period of 2026–2035 ,. The market is witnessing rapid growth as businesses increasingly adopt distributed computing technologies to process data closer to its source rather than relying entirely on centralized cloud infrastructure. Edge computing enables faster data processing, reduced latency, improved network efficiency, and real-time decision-making across industries. The technology is gaining importance in industrial automation, smart cities, connected vehicles, healthcare, retail, telecommunications, and Internet of Things (IoT) applications. Increasing integration of artificial intelligence, 5G connectivity, edge servers, and cloud-based platforms is further strengthening market adoption. The growing need for secure, scalable, and reliable computing infrastructure is encouraging orga...

  Market Overview According to MarketGenics, the global mRNA Vaccines Market was valued at USD 10.3 billion in 2025 and is projected to reach USD 39.5 billion by 2035 , registering a CAGR of 14.4% during the forecast period of 2025–2035 . The market is experiencing significant growth as messenger RNA (mRNA) technology continues to transform vaccine development and preventive healthcare. mRNA vaccines use genetic instructions to help cells produce specific proteins that trigger an immune response against targeted diseases. Following the successful development and commercialization of COVID-19 vaccines, pharmaceutical and biotechnology companies are expanding their research into mRNA-based vaccines for influenza, respiratory syncytial virus (RSV), cancer prevention, and other infectious and chronic diseases. Advancements in lipid nanoparticle (LNP) delivery systems, self-amplifying mRNA technology, and scalable manufacturing processes are further strengthening the market. Increas...

  Market Overview According to MarketGenics, the global Neurodegenerative Disorders Market was valued at USD 39.8 billion in 2025 and is projected to reach USD 69.9 billion by 2035 , registering a CAGR of 5.8% during the forecast period of 2026–2035 . The market is witnessing steady growth due to the increasing prevalence of neurological conditions, including Alzheimer's disease, Parkinson's disease, Huntington's disease, amyotrophic lateral sclerosis (ALS), and multiple sclerosis. Neurodegenerative disorders are characterized by the progressive deterioration of nerve cells, affecting memory, movement, cognitive abilities, and overall neurological functioning. The growing demand for effective treatment options, early diagnosis, and disease-management solutions is encouraging pharmaceutical and biotechnology companies to invest in advanced therapeutic development. Increasing research into disease-modifying treatments, biologics, gene therapies, and precision medicine is ...

  Market Overview According to MarketGenics, the global Next-Gen Clinical Decision Support Market was valued at USD 1.7 billion in 2025 and is projected to reach USD 7.6 billion by 2035 , registering a CAGR of 16.2% during the forecast period of 2026–2035 . The market is experiencing strong growth as healthcare organizations increasingly adopt advanced clinical decision support solutions to improve diagnostic accuracy, treatment planning, patient safety, and clinical workflow efficiency. Next-generation clinical decision support systems integrate artificial intelligence, machine learning, predictive analytics, real-time patient data, and evidence-based medical guidelines to assist healthcare professionals in making informed clinical decisions. These solutions are increasingly integrated with electronic health records (EHR), electronic medical records (EMR), laboratory information systems, and radiology platforms to provide relevant clinical insights at the point of care. The gr...

  Market Overview According to MarketGenics, the global Novel Drugs Market was valued at USD 193.6 billion in 2025 and is projected to reach USD 406.5 billion by 2035 , registering a CAGR of 7.7% during the forecast period of 2026–2035 . The market is experiencing significant growth as pharmaceutical and biotechnology companies increasingly focus on developing innovative medicines to address unmet medical needs and improve treatment outcomes. Novel drugs include newly developed small-molecule drugs, biologics, gene therapies, cell therapies, RNA-based therapeutics, peptide therapeutics, and protein-based treatments. Growing advancements in biotechnology, molecular research, precision medicine, and drug discovery are creating opportunities for the development of more targeted and effective therapies. Biologics represent a major segment of the market, supported by their ability to address complex diseases through highly specific treatment approaches. Increasing investment in phar...